TC BioPharm(TCBP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TCBP TC BioPharm

盘后交易 12-18 16:21:29 EST

0.6500

+0.1810

+38.59%

盘后0.7050

+0.0550+8.46%

16:21 EST

最高0.8210	最低0.5560	成交量2,915万
今开0.8043	昨收0.4690	日振幅56.50%
总市值533.51万	流通市值533.34万	总股本820.79万
成交额2,207万	换手率355.22%	流通股本820.53万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TCBP","market":"US","secType":"STK","nameCN":"TC BioPharm","latestPrice":0.65,"timestamp":1734555600000,"preClose":0.469,"halted":0,"volume":29147105,"hourTrading":{"tag":"盘后","latestPrice":0.705,"preClose":0.65,"latestTime":"16:21 EST","volume":10278,"amount":6718.5925192800005,"timestamp":1734556874242},"delay":0,"floatShares":8205300,"shares":8207900,"eps":-164.45044,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.181,"latestTime":"12-18 16:21:29 EST","open":0.8043,"high":0.821,"low":0.556,"amount":22073058.02142935,"amplitude":0.565032,"askPrice":0.74,"askSize":20,"bidPrice":0.6699,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-164.45044,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1734570000000},"adr":0,"listingDate":1644555600000,"adjPreClose":0.469,"adrRate":200,"preHourTrading":{"tag":"盘前","latestPrice":0.821,"preClose":0.469,"latestTime":"09:29 EST","volume":4712991,"amount":4618737.3068883,"timestamp":1734532196652},"postHourTrading":{"tag":"盘后","latestPrice":0.705,"preClose":0.65,"latestTime":"16:21 EST","volume":10278,"amount":6718.5925192800005,"timestamp":1734556874242},"volumeRatio":94.886138},"requestUrl":"/m/hq/s/TCBP/wiki","defaultTab":"wiki","newsList":[{"id":"2492181637","title":"Tc Biopharm (Holdings) Plc股价上涨60.79% 市值涨376.29万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492181637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492181637?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:33","pubTimestamp":1734532383,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时33分，Tc Biopharm  Plc股票出现异动，股价急速拉升60.79%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Cognition Therapeutics, Inc.、Polyrizon Ltd.、Tc Biopharm  Plc涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1011.37%、300.50%、241.07%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Cognition Therapeutics, Inc.、Polyrizon Ltd.，振幅分别为66.83%、37.37%、24.76%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218223304a1f8c253&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218223304a1f8c253&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGTX","BK4007","BK4139","TCBP"],"gpt_icon":0},{"id":"2492969327","title":"Tc Biopharm (Holdings) Plc盘中异动 股价大跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492969327","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492969327?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:45","pubTimestamp":1734446730,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日22时45分，Tc Biopharm  Plc股票出现异动，股价大幅下挫5.44%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.66%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121722453095ea327d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121722453095ea327d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2491697604","title":"Tc Biopharm (Holdings) Plc盘中异动 股价大跌5.27%报0.501美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491697604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491697604?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:31","pubTimestamp":1734359474,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时31分，Tc Biopharm  Plc股票出现异动，股价急速下跌5.27%。截至发稿，该股报0.501美元/股，成交量1.5079万股，换手率0.18%，振幅0.00%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.02%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223117ab7c935a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223117ab7c935a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2491377415","title":"Tc Biopharm (Holdings) Plc盘中异动 早盘快速下跌15.23%报0.495美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491377415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491377415?lang=zh_cn&edition=full","pubTime":"2024-12-14 00:12","pubTimestamp":1734106321,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日00时12分，Tc Biopharm  Plc股票出现波动，股价急速跳水15.23%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.44%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214001201ab75bac7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214001201ab75bac7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2490043845","title":"Tc Biopharm (Holdings) Plc盘中异动 股价大跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490043845","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490043845?lang=zh_cn&edition=full","pubTime":"2024-12-10 23:13","pubTimestamp":1733843622,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日23时13分，Tc Biopharm  Plc股票出现波动，股价大幅下跌5.27%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为1.42%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210231342ab6d09e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210231342ab6d09e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2488519427","title":"Tc Biopharm (Holdings) Plc盘中异动 早盘股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488519427","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488519427?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:31","pubTimestamp":1733322669,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时31分，Tc Biopharm  Plc股票出现波动，股价大幅上涨5.02%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，Cyclerion Therapeutics, Inc.、Heron Therapeutics, Inc.、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为1203.02%、189.46%、109.61%，振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Heron Therapeutics, Inc.、Synaptogenix, Inc.，振幅分别为32.30%、22.88%、8.61%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120422311098e55c88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120422311098e55c88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2488670026","title":"Tc Biopharm (Holdings) Plc盘中异动 股价大跌8.56%报0.512美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488670026","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488670026?lang=zh_cn&edition=full","pubTime":"2024-12-02 23:15","pubTimestamp":1733152545,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日23时15分，Tc Biopharm  Plc股票出现波动，股价大幅下跌8.56%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.01%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202231545abf0190d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202231545abf0190d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2486706728","title":"Tc Biopharm (Holdings) Plc盘中异动 大幅下挫5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486706728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486706728?lang=zh_cn&edition=full","pubTime":"2024-11-28 01:32","pubTimestamp":1732728731,"startTime":"0","endTime":"0","summary":"北京时间2024年11月28日01时32分，Tc Biopharm  Plc股票出现异动，股价快速跳水5.24%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.83%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112801321298e44fc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112801321298e44fc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2486002827","title":"Tc Biopharm (Holdings) Plc盘中异动 早盘股价大跌5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486002827","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486002827?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:39","pubTimestamp":1732631975,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时39分，Tc Biopharm  Plc股票出现异动，股价快速下挫5.47%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.40%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112622393598e44aa4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112622393598e44aa4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2486058441","title":"Tc Biopharm (Holdings) Plc盘中异动 快速上涨6.19%报0.663美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486058441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486058441?lang=zh_cn&edition=full","pubTime":"2024-11-26 01:43","pubTimestamp":1732556616,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日01时43分，Tc Biopharm  Plc股票出现波动，股价快速拉升6.19%。截至发稿，该股报0.663美元/股，成交量30.92万股，换手率54.05%，振幅7.21%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为1.70%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126014336a254e192&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126014336a254e192&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2485267621","title":"Tc Biopharm (Holdings) Plc盘中异动 早盘股价大跌6.14%报0.591美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485267621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485267621?lang=zh_cn&edition=full","pubTime":"2024-11-22 23:22","pubTimestamp":1732288924,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日23时22分，Tc Biopharm  Plc股票出现异动，股价大幅下跌6.14%。截至发稿，该股报0.591美元/股，成交量11.4553万股，换手率20.03%，振幅4.76%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.66%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122232204a24e3805&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122232204a24e3805&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VRPX","TCBP","BK4007"],"gpt_icon":0},{"id":"2485418184","title":"Tc Biopharm (Holdings) Plc盘中异动 急速跳水6.19%报0.591美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485418184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485418184?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:59","pubTimestamp":1732201168,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时59分，Tc Biopharm  Plc股票出现异动，股价快速下挫6.19%。截至发稿，该股报0.591美元/股，成交量8.7246万股，换手率15.25%，振幅6.40%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.54%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122592898e43f13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122592898e43f13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2485442128","title":"Tc Biopharm (Holdings) Plc盘中异动 股价大涨5.81%报0.630美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485442128","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485442128?lang=zh_cn&edition=full","pubTime":"2024-11-21 01:34","pubTimestamp":1732124053,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日01时34分，Tc Biopharm  Plc股票出现异动，股价急速拉升5.81%。截至发稿，该股报0.630美元/股，成交量33.899万股，换手率59.26%，振幅7.56%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.70%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121013413abd28201&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121013413abd28201&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2484925294","title":"Tc Biopharm (Holdings) Plc盘中异动 早盘大幅下挫5.07%报0.580美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484925294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484925294?lang=zh_cn&edition=full","pubTime":"2024-11-19 23:05","pubTimestamp":1732028712,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日23时05分，Tc Biopharm  Plc股票出现异动，股价快速跳水5.07%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为1.47%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119230513971a773c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119230513971a773c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2484679827","title":"Tc Biopharm (Holdings) Plc盘中异动 股价大跌6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484679827","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484679827?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:32","pubTimestamp":1731940323,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时32分，Tc Biopharm  Plc股票出现波动，股价大幅跳水6.34%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.30%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118223203971a7277&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118223203971a7277&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2483377141","title":"Tc Biopharm (Holdings) Plc股价飙升17.29% 市值涨7.52万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483377141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483377141?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:31","pubTimestamp":1731681085,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时31分，Tc Biopharm  Plc股票出现异动，股价急速拉升17.29%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.69%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522312595be340a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522312595be340a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2483884323","title":"Tc Biopharm (Holdings) Plc盘中异动 早盘急速下跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483884323","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483884323?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:38","pubTimestamp":1731508688,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时38分，Tc Biopharm  Plc股票出现波动，股价大幅下跌5.31%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.16%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223808abbde0ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223808abbde0ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2482573872","title":"Tc Biopharm (Holdings) Plc盘中异动 快速下挫5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482573872","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482573872?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:40","pubTimestamp":1731336010,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时40分，Tc Biopharm  Plc股票出现波动，股价快速下挫5.26%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.09%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111224010abb666bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111224010abb666bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2481184900","title":"Tc Biopharm (Holdings) Plc盘中异动 急速拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481184900","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481184900?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:11","pubTimestamp":1730992297,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时11分，Tc Biopharm  Plc股票出现异动，股价大幅拉升5.26%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.10%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723113798e413a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723113798e413a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2481198504","title":"Tc Biopharm (Holdings) Plc盘中异动 早盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481198504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481198504?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:50","pubTimestamp":1730904639,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时50分，Tc Biopharm  Plc股票出现波动，股价大幅跳水5.19%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.94%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622504098e40e81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622504098e40e81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tcbiopharm.com","stockEarnings":[{"period":"1week","weight":-0.1957},{"period":"1month","weight":-0.2915},{"period":"3month","weight":-0.9295},{"period":"6month","weight":-0.9448},{"period":"1year","weight":-0.982},{"period":"ytd","weight":-0.9852}],"compareEarnings":[{"period":"1week","weight":0.0025},{"period":"1month","weight":0.0317},{"period":"3month","weight":0.0764},{"period":"6month","weight":0.1047},{"period":"1year","weight":0.2804},{"period":"ytd","weight":0.2714}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"TC BioPharm (Holdings) plc.是一家于2021年10月25日根据苏格兰法律注册成立的公司。TC BioPharm 是一家临床阶段的生物制药公司，专注于基于其专有的同种异体gamma delta T (GD-T)细胞平台开发新型免疫治疗产品。利用GD-T的先天能力，TCB能够开发一系列旨在对抗癌症和病毒感染的临床阶段细胞疗法。","exchange":"NASDAQ","name":"TC BioPharm","nameEN":"TC BioPharm"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TC BioPharm(TCBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TC BioPharm(TCBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TC BioPharm,TCBP,TC BioPharm股票,TC BioPharm股票老虎,TC BioPharm股票老虎国际,TC BioPharm行情,TC BioPharm股票行情,TC BioPharm股价,TC BioPharm股市,TC BioPharm股票价格,TC BioPharm股票交易,TC BioPharm股票购买,TC BioPharm股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TC BioPharm(TCBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TC BioPharm(TCBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}